Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.940
+0.050 (1.73%)
Aug 12, 2026, 4:00 PM EDT - Market closed
Cellectis Market Cap
Cellectis has a market cap or net worth of $223.2 million as of August 12, 2026. Its market cap has increased by 16.43% in one year.
Market Cap
223.20M
Enterprise Value
135.97M
1-Year Change
16.43%
Ranking
Category
Stock Price
$2.94
ChartMarket Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $223.20M, a decrease of -83.39%. That is a compound annual growth rate of -14.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 213.70M | -38.96% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 213.74M |
| NovaBridge Biosciences | 212.79M |
| Tonix Pharmaceuticals Holding | 211.64M |
| AN2 Therapeutics | 211.41M |
| Outlook Therapeutics | 211.31M |
| Keros Therapeutics | 210.96M |
| Immunic | 210.86M |
| Atrium Therapeutics | 209.89M |